(Q43091360)

13 November 2017

title

A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

13 November 2017

0 references

1 reference

10

1 reference

13 November 2017

Marc Solioz

7

0 references

author name string

Elmar Aigner

1

1 reference

13 November 2017

Michael Strasser

2

1 reference

13 November 2017

Heike Haufe

3

1 reference

13 November 2017

Thomas Sonnweber

4

1 reference

13 November 2017

Florian Hohla

5

1 reference

13 November 2017

Andreas Stadlmayr

6

1 reference

13 November 2017

Herbert Tilg

8

1 reference

13 November 2017

Wolfgang Patsch

9

1 reference

13 November 2017

Felix Stickel

11

1 reference

13 November 2017

Christian Datz

12

1 reference

13 November 2017

language of work or name

English

0 references

publication date

20 April 2010

1 reference

The American Journal of Gastroenterology

13 November 2017

published in

1 reference

13 November 2017

volume

105

1 reference

13 November 2017

issue

9

1 reference

13 November 2017

page(s)

1978-1985

1 reference

Fatty liver and the metabolic syndrome

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Pathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Recent advances in nonalcholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Cyclooxygenase-2 is upregulated in copper-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Insulin resistance-associated hepatic iron overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Nonalcoholic fatty liver disease and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

How reliable and robust are current biomarkers for copper status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Role of mitochondria in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

The ins and outs of mitochondrial dysfunction in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Recent concepts in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

The role of cytokines and chemokines in the development of steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.170

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.170

1 reference

13 November 2017

1 reference